Results 211 to 220 of about 961,893 (364)
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source
Excess fibroblast growth factor 23 in alcoholic osteomalacia is derived from the bone. [PDF]
Hidaka N+21 more
europepmc +1 more source
This proof‐of‐concept study involves high‐throughput teratogenicity screening of compounds using XEn/EpiCs, a 3D stem cell‐based embryo model, within microwells. The term ‘morphotoxicity’ is introduced to complement traditional cytotoxicity assays through automated feature extraction and machine‐learning‐assisted classification of morphologies.
Vinidhra Shankar+4 more
wiley +1 more source
Fibroblast growth factor 23 predicts incident diabetic kidney disease: A 4.6-year prospective study. [PDF]
Liu D+14 more
europepmc +1 more source
Rod‐shaped particles outperform spherical particles of the same volume in preventing neutrophil infiltration to inflamed areas, both in vitro and in vivo. This therapeutic effectiveness is attributed to better cell targeting and decreased cell motility, resulting from the geometry‐driven phagocytosis and inhibited actin polymerization.
M. Valentina Guevara+7 more
wiley +1 more source
Fibroblast Growth Factor 23 in COVID-19: An Observational Study. [PDF]
Myrou A+11 more
europepmc +1 more source
Intravenous iron replacement therapy is a common treatment for iron deficiency. Commonly used agents in this treatment include ferric carboxymaltose, ferric derisomaltose, and saccharated ferric oxide (SFO).
Teruhisa Kinoshita+5 more
doaj